760 related articles for article (PubMed ID: 19786693)
1. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
2. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
[TBL] [Abstract][Full Text] [Related]
3. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
[TBL] [Abstract][Full Text] [Related]
5. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
6. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.
Viiri LE; Viiri KM; Ilveskoski E; Huhtala H; Mäki M; Tienari PJ; Perola M; Lehtimäki T; Karhunen PJ
Circ Cardiovasc Genet; 2008 Dec; 1(2):107-16. PubMed ID: 20031552
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
Van der Walt A; Stankovich J; Bahlo M; Taylor BV; Van der Mei IA; Foote SJ; Rubio JP; Kilpatrick TJ; Butzkueven H
Mult Scler; 2011 Mar; 17(3):344-52. PubMed ID: 21149397
[TBL] [Abstract][Full Text] [Related]
8. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients].
Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J
Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
10. ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis.
Portaccio E; Zipoli V; Goretti B; Hakiki B; Nacmias B; Siracusa G; Sorbi S; Amato MP
Acta Neurol Scand; 2009 Dec; 120(6):439-41. PubMed ID: 19804477
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein epsilon4 allele is associated with psoriasis severity.
Coto-Segura P; Coto E; Alvarez V; Morales B; Soto-Sánchez J; Corao AI; Santos-Juanes J
Arch Dermatol Res; 2010 Mar; 302(2):145-9. PubMed ID: 19911187
[TBL] [Abstract][Full Text] [Related]
12. Distribution of APOE genotypes in a memory clinic cohort.
van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P
Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171
[TBL] [Abstract][Full Text] [Related]
13. Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene.
Fritsche LG; Freitag-Wolf S; Bettecken T; Meitinger T; Keilhauer CN; Krawczak M; Weber BH
Hum Mutat; 2009 Jul; 30(7):1048-53. PubMed ID: 19384966
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
15. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
Tamam Y; Tasdemir N; Yalman M; Tamam B
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
[TBL] [Abstract][Full Text] [Related]
17. The missing ApoE allele.
Seripa D; Matera MG; Daniele A; Bizzarro A; Rinaldi M; Gravina C; Bisceglia L; Corbo RM; Panza F; Solfrizzi V; Fazio VM; Forno GD; Masullo C; Dallapiccola B; Pilotto A
Ann Hum Genet; 2007 Jul; 71(Pt 4):496-500. PubMed ID: 17244188
[TBL] [Abstract][Full Text] [Related]
18. Association of the apolipoprotein E gene, its promoter polymorphisms and haplotypes with depressive symptoms. The Cardiovascular Risk in Young Finns Study.
Elovainio M; Puttonen S; Pulkki-Råback L; Kivimaki M; Viiri LE; Lehtimaki T; Karhunen P; Viikari J; Raitakari OT; Keltikangas-Jarvinen L
Neuropsychobiology; 2008; 58(2):91-6. PubMed ID: 18843194
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype and cerebral palsy.
Braga LW; Borigato EV; Speck-Martins CE; Imamura EU; Gorges AM; Izumi AP; Dantas RC; Nunes LG
Dev Med Child Neurol; 2010 Jul; 52(7):666-71. PubMed ID: 20002130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
